 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Novavax, Inc.
 |
Novavax, Inc. |
 |
 |
 |
PROFILE |
 |
Novavax has a thing for women and their health. After buying Fielding Pharmaceutical (now a subsidiary), the company focuses primarily on developing and selling prescription and OTC products for women. Marketed products include pre-natal vitamins, oral contraceptives, and hormone replacement therapies. The firm is working on two topical creams, ESTRASORB and ANDROSORB, which deliver estrogen and testosterone through the skin. Infectious diseases are another focus: Novavax is developing vaccines for human papilloma virus, hepatitis E, dengue fever, malaria, and the flu with King Pharmaceuticals (which has a minority stake in the firm) and the National Institutes of Health.
COMPETITION |
 |
ALZA Corporation (dossier)
Elan Corporation, plc (ELN)
Gilead Sciences, Inc. (GILD)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 2.50
1-Yr. Sales Growth: 108.3%
Employees: 127
Revenue per employee: $19,685.04
KEY PEOPLE |
 |
John A. Spears
CEO
Dennis W. Genge
CFO
CONTACT INFO |
 |
8320 Guilford Rd.
Columbia, MD 21046
US
Phone: 301-854-3900
Fax: 301-854-3901
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |